CHEN Y, DU X P. A general practice-based approach to the management of resistant hypertension first diagnosed in the community[J]. Chinese General Practice, 2022, 25 (19) : 2429-2434.
Yang CHEN,Xueping DU. A General Practice-based Approach to the Management of Resistant Hypertension First Diagnosed in the Community[J]. Chinese General Practice, 2022, 25(19): 2429-2434. DOI: 10.12114/j.issn.1007-9572.2022.0157.
陈瑒,杜雪平. 首诊难治性高血压的全科诊治思路[J]. 中国全科医学, 2022, 25(19): 2429-2434. DOI: 10.12114/j.issn.1007-9572.2022.0157.
ARMARIOP,CALHOUND A,OLIVERASA,et al. Prevalence and clinical characteristics of refractory hypertension[J]. J Am Heart Assoc,2017,6(12):e007365. DOI: 10.1161/JAHA.117.007365.
[3]
TSIOUFISC,KASIAKOGIASA,KORDALISA,et al. Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity:a 4-year prospective study[J]. J Hypertension,2014,32(2):415-422. DOI:10.1097/hjh.0000000000000023.
[4]
CAREYR M,CALHOUND A,BAKRISG L,et al. Resistant hypertension:detection,evaluation,and management. A scientific statement from the American Heart Association[J]. Hypertension,2018,72(5):e53-90. DOI:10.1161/HYP.0000000000000084.
HIREMATHS,SAPIR-PICHHADZER,NAKHLAM,et al. Hypertension Canada's 2020 evidence review and guidelines for the management of resistant hypertension[J]. Can J Cardiol,2020,36(5):625-634. DOI:10.1016/j.cja.2020.02.083.
The American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc,2019,67(4):674-694. DOI:10.1111/jgs.15767.
KLINEG A,PREBTANIA P,LEUNGA A,et al. Primary aldosteronism:a common cause of resistant hypertension[J].CMAJ,2017,189(22):e773-778. DOI:10.1503/cmaj.161486.